Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer
Disulfidptosis is a newly discovered formation of programmed cell death. However, the significance of disulfidptosis in pancreatic adenocarcinoma remains unclear. Our investigation aims to elucidate the significance of disulfidptosis in pancreatic ductal adenocarcinoma by integrating diverse dataset...
Saved in:
| Main Authors: | Ran Cui, Gaoming Wang, Renhao Hu, Yongkun Wang, Huiling Mu, Yanxiang Song, Bo Chen, Xiaohua Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1568976/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma
by: Jingyang Yin, et al.
Published: (2025-03-01) -
Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma
by: Bingxin Zhang, et al.
Published: (2025-04-01) -
Disulfidptosis-based molecular clustering and prognostic signatures predict patient survival and the immune landscape in patients with colon cancer
by: Liang Wen, et al.
Published: (2025-03-01) -
Disulfidptosis classification of pancreatic carcinoma reveals correlation with clinical prognosis and immune profile
by: Jiangmin Shi, et al.
Published: (2025-02-01) -
Disulfidptosis-related LncRNAs forecast the prognosis of acute myeloid leukemia
by: Pei Xu, et al.
Published: (2025-04-01)